posted
DOBI Medical International to Exhibit ComfortScan(R) System at 2006 CHINA MED DOBI Medical International, Inc. (DBMI.OB) will premiere its latest Dynamic Optical Breast Imaging (DOBI(R)) technology, known as the ComfortScan(R) system, at the 2006 CHINA MED International Medical Instruments and Equipment Exhibition Conference, April 11-14, at the China International Exhibition Centre, Beijing, China, in Booth 8B090.
One of the leading exhibitions in Asia, last year's CHINA MED drew a record 37,000 trade visitors. This year more than 400 exhibitors are expected to participate in what is the 18th annual exhibition of worldwide innovative technologies. As in recent years, over 60% of the exhibitors will be from outside of China, including the U.S. and Europe.
According to the Global Cancer Statistics 2002 report from The American Cancer Society (ACS), breast cancer, is by far the most frequent cancer among women. There were an estimated 1.15 million new cases in 2002, while Chinese cancer registries report steady annual increases in incidence of 3 to 4%.
The ComfortScan system is an investigational digital-imaging system utilizing high-intensity, light-emitting diodes and gentle external pressure to highlight areas with vascular abnormalities in the breast. ComfortScan technology is based on identifying tumor angiogenesis, the process whereby a cancerous growth surrounds itself with a dense network of tiny blood-filled capillaries which serve to aid in its growth and development. The ComfortScan system is designed to be used as an adjunct to mammography, and clinical trials are evaluating its ability to provide additional information which may aid the physician in diagnosing breast cancer more effectively.
About DOBI Medical International, Inc.
DOBI Medical is a developmental stage, medical imaging company working to create a new means for the improved diagnosis of malignant breast disease through the identification of abnormal vascularization ("angiogenesis") associated with tumors. The Company's first application of the technology is the ComfortScan(R) system, a gentle, noninvasive, and nonionizing, optical imaging system designed to assist physicians in the identification and management of breast cancer as an adjunct to screening mammography. The ComfortScan system is intended to achieve this by providing new, physiology-based imagery of abnormal vascularization in the breast that is not readily available today. The ComfortScan system has CE Mark and UL designations, and DOBI Medical is a certified ISO 9001:2000, ISO 13485:2003 and CAN/CSA:ISO 13485 company. The ComfortScan system is not yet commercially available in the U.S. as it is limited by U.S. law to investigational use until approved by the FDA, which cannot be guaranteed. Sales of the ComfortScan system to international distributors are limited to sales for investigational use for installation at clinical trial sites. For more information on DOBI Medical International or the ComfortScan system, visit www.dobimedical.com.
this can be very interesting in the next days/weeks..keep an eye on it
Posts: 1065 | From: switzerland | Registered: Mar 2005
| IP: Logged |
UBBFriend: Email this page to someone!
Printer-friendly view of this topic
